Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hisanori Wakita is active.

Publication


Featured researches published by Hisanori Wakita.


Tetrahedron | 1999

SYNTHESIS OF 5,6,7-TRINOR-4,8-INTER-M-PHENYLENE PGI2 AND BERAPROST

Hisanori Wakita; Kazuhisa Matsumoto; Hideo Yoshiwara; Yutaka Hosono; Ryoji Hayashi; Hisao Nishiyama; Hiroshi Nagase

Abstract We have disclosed a new class of stable PGI 2 analogue, 5,6,7-trinor-4,8-inter- m -phenylene PGI 2 which has a phenyl ether moiety instead of enol-ether skeleton in PGI 2 . The m -phenylene PGI 2 and its derivative (Beraprost) were synthesized via dihydrocyclopenta[ b ]benzofuran derivatives as key intermediates by ortho -selective metal-halogen exchange reaction with Grignard reagents and subsequent copper-catalyzed cyclization. The ω-side chains were introduced by stereoselective epoxide formation or Prins reaction.


Tetrahedron-asymmetry | 1999

Preparative resolution of a key intermediate for the synthesis of optically active m-phenylene PGI2 derivatives

Hisanori Wakita; Hideo Yoshiwara; Atsuko Tajima; Yukishige Kitano; Hiroshi Nagase

Abstract A key intermediate for the synthesis of optically active m -phenylene PGI 2 derivatives was efficiently resolved on a preparative scale by diastereomeric salt formation method using (+)- cis - N -benzyl-2-(hydroxymethyl)cyclohexylamine ((+)- cis -amine) as a resolving agent.


Tetrahedron-asymmetry | 2000

Preparative resolution of 2-methyl-4-hexynic acid for the synthesis of optically active m-phenylene PGI2 derivatives and determination of their absolute configuration

Hisanori Wakita; Hideo Yoshiwara; Yukishige Kitano; Hisao Nishiyama; Hiroshi Nagase

Abstract Racemic 2-methyl-4-hexynic acid, which is a starting material for the ω-side chain of the PGI2 derivatives, Beraprost and Iloprost, was efficiently resolved on a preparative scale by diastereomeric salt formation using quinine and cinchonidine as resolving agents. Their absolute configuration was determined by X-ray analyses of Beraprost derivatives.


Chemical & Pharmaceutical Bulletin | 1998

Rational Drug Design and Synthesis of a Highly Selective Nonpeptide δ-Opioid Agonist, (4aS*, 12aR*)-4a-(3-Hydroxyphenyl)-2-methyl-1, 2, 3, 4, 4a, 5, 12, 12a-octahydropyrido[3, 4-b]acridine (TAN-67)

Hiroshi Nagase; Koji Kawai; Jun Hayakawa; Hisanori Wakita; Akira Mizusuna; Hirotoshi Matsuura; Chiko Tajima; Yuko Takezawa; Takashi Endoh


Bioorganic & Medicinal Chemistry | 2008

Design, synthesis, and structure–activity relationship of novel opioid κ-agonists

Koji Kawai; Jun Hayakawa; Toru Miyamoto; Yoshifumi Imamura; Shinichi Yamane; Hisanori Wakita; Hideaki Fujii; Kuniaki Kawamura; Hirotoshi Matsuura; Naoki Izumimoto; Ryosuke Kobayashi; Takashi Endo; Hiroshi Nagase


Archive | 1990

2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives

Kiyotaka Ohno; Atsushi Ohtake; Hiroshi Nagase; Shintaro Nishio; Toshiya Takahashi; Hisanori Wakita


Synlett | 1998

Synthesis of Optically Active Cyclopenta[b]benzofuran as a Precursor of m-Phenyleneprostacyclin

Hisao Nishiyama; Naoya Sakata; Hayato Sugimoto; Yukihiro Motoyama; Hisanori Wakita; Hiroshi Nagase


Heterocycles | 2000

Total Synthesis of Optically Active m-Phenylene PGl2 Derivative: Beraprost

Hiroshi Nagase; Hisanori Wakita; Hideo Yoshiwara; Hisao Nishiyama


Archive | 1998

Cervical maturing agent

Yasuo Ochi; Naohiro Yamada; Hisanori Wakita; Masami Moriyama


Archive | 2006

Crystals of Morphinan Derivative and Process for Producing the Same

Hisanori Wakita; Masahiro Akimoto; Takahiro Takeda

Collaboration


Dive into the Hisanori Wakita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge